Moving into human data, multiple studies demonstrated that both PD-1 and PD-L1 were expressed at low levels in patients with active SLE and that this was in correlation with disease activity (Dai et al., 2014; Curran et al., 2019). This evidence concerns the gene PDCD1 and systemic lupus erythematosus.